患者报告结局在分子肿瘤委员会指导诊疗中的前景与局限:迈向以患者为中心的精准肿瘤学框架
The promise and limits of patient-reported outcomes in molecular tumor board-guided care: toward a framework for patient-centered precision oncology
患者报告结局在分子肿瘤委员会指导的诊疗中兼具应用前景与局限,相关讨论提出以患者为中心的精准肿瘤学框架。该框架的构建聚焦患者报告结局在精准肿瘤学决策中的应用边界。
Acknowledgements
We gratefully acknowledge the fruitful discussions and expert advice provided by all members of the PM4Onco consortium. In particular, we extend our special thanks to Dr. Brita Sedlmayr and Dr. Martin Eichler for their invaluable insights and contributions to the development of this work. This work was supported by the German Federal Ministry of Research, Technology, and Space (BMFTR) under the projects PM4Onco (PM4Onco - 01ZZ2322A, 01ZZ2322I, and 01ZZ2322R), MiHUBx (01ZZ2101A), PCOR-MII (01ZZ2321), and MTB-Alliance (01KD2403). Open Access funding enabled and organized by Projekt DEAL. We gratefully acknowledge support from the SLUB/TU Dresden Open Access Publication Fund. The funder had no role in the conceptualization, writing, or decision to submit this manuscript. Declaration of generative AI and AI-assisted technologies: For the preparation and revision of this article, the authors used ChatGPT (OpenAI) for language editing and stylistic revision. All scientific arguments, interpretations, conclusions, and final manuscript content were reviewed, verified, and approved by the authors. After using this tool, the authors take full responsibility for the published work.
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Author notes
These authors contributed equally: L. Gräßel, S. Yacob.
Authors and Affiliations
Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany
L. Gräßel, S. Yacob & AL Illert
Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
L. Gräßel
Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
C. Strantz
Institute for Medical Informatics and Biometry, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
E. Prochaska, S. Bäcker & M. Wolfien
Charité - Universitätsmedizin Berlin, Berlin Institute of Health @ Charité, Berlin, Germany
T. Debertshäuser & F. Prasser
Center for Patient-Centered Outcomes Research, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Charité Platz 1, Berlin, Germany
AA. Rogge
Department of Psychosomatic Medicine, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany
AA. Rogge
Medical Center for Information and Communication Technology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
P. Unberath
SRH Fürth University of Applied Sciences, Fürth, Germany
P. Unberath
Data Integration Center, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Freiburg, Germany
J. Wehrle
Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
S. Jäger & M. Boerries
Department I of Internal Medicine, Center for Integrated Oncology Cologne, University Hospital Cologne, Cologne, Germany
U. Lührig
Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI Dresden/Leipzig), Dresden, Saxony, Germany
M. Wolfien
Authors
- L. Gräßel
- S. Yacob
- C. Strantz
- E. Prochaska
- T. Debertshäuser
- AA. Rogge
- S. Bäcker
- F. Prasser
- P. Unberath
- J. Wehrle
- S. Jäger
- M. Boerries
- AL Illert
- U. Lührig
- M. Wolfien
Corresponding author
Correspondence to M. Wolfien.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Gräßel, L., Yacob, S., Strantz, C. et al. The promise and limits of patient-reported outcomes in molecular tumor board-guided care: toward a framework for patient-centered precision oncology. npj Precis. Onc. (2026). https://doi.org/10.1038/s41698-026-01719-0
Received: 15 August 2025
Accepted: 12 September 2026
Published: 29 October 2026
DOI: https://doi.org/10.1038/s41698-026-01719-0
来源:Nature 健康护理主题 · nature.com